Navigation Links
Eurofins MWG Operon signs contract to supply oligonucleotides to Research Councils
Date:8/10/2010

Ebersberg, Germany, August 10, 2010 Eurofins MWG Operon, international market leader and expert for custom oligonucleotide synthesis and RCUK Shared Services Centre Limited (RCUK SSC Ltd) have signed a three year contract for the supply of synthetic DNA & RNA oligonucleotides. This long term contract builds on the relationship developed as a preferred supplier to the Medical Research Council (MRC) during the previous four years.

RCUK SSC Ltd has been set up by the seven Research Councils of the UK (RCUK) to provide centralised services to the Research Councils and their institutes in; human resources (HR), finance, procurement, Information Technology, Information Systems and grants processing. By adopting a shared services approach, the Research Councils are making financial savings, and are at the same time increasing their operational efficiency.

"We are very proud that RCUK SSC Ltd has selected Eurofins MWG Operon as one of their service providers of choice, on behalf of the UK's Research Councils and continues our business relationship" says Bruno Poddevin, Eurofins Senior Vice President, Genomic Services. "By signing the three year contract, RCUK SSC Ltd confirms their trust in our product quality and outstanding service with which Eurofins MWG Operon has identified itself for more than twenty years."

Richard Fowles, Category Manager with RCUK SSC Ltd commented, "We are very pleased to be able to announce Eurofins MWG Operon is to be one of our preferred suppliers of oligos. We feel that their great product offering will be of significant benefit to researchers."

Eurofins MWG Operon also provides best in class next generation sequencing services, Sanger sequencing, siRNA and gene synthesis services and is committed to continually optimizing and improving processes and product quality to ensure that they deliver their products and services in the fastest and most convenient manner possible.


'/>"/>

Contact: Dr. Jutta Huber
juttahuber@eurofins.com
49-809-282-89930
Eurofins MWG Operon
Source:Eurekalert

Page: 1

Related biology news :

1. Verizon Business to Provide Global IP for Eurofins Scientific
2. Eurofins MWG Operon and Genomatix launch strategic alliance
3. Eurofins MWG Operon and Genomatix developed most complete human exome array
4. bioMETRX, Inc. Signs Deal To Acquire Controlling Interest in Biometric Solutions, LLC
5. Unifying the animate and the inanimate designs of nature
6. University of Miami engineer designs stretchable electronics with a twist
7. Engineering technology pinpoints earliest signs of animal life
8. La Jolla Institute signs exclusive license agreement with Medimmune on major asthma discovery
9. UK robot sub searches for signs of melting 60 km into an Antarctic ice shelf cavity
10. Ben-Gurion University of the Negev signs collaborative contract with Bayer CropScience
11. WARF signs license agreement with Pfizer for human embryonic stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/31/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company ... of bacterial infections, today announced it has acquired ... Pro Bono Bio Ltd (PBB) to bolster its ... forms of Gram-negative bacteria.   The assets acquired have ... PBB group company. "The acquisition of ...
(Date:1/26/2017)... DENVER , Jan. 26, 2017  Acuity ... Trends for Biometrics and Digital Identity".  Acuity characterizes ... digital identity when increased adoption reflects a new ... "Biometrics and digital identity are ... says Maxine Most , Principal of Acuity ...
(Date:1/24/2017)... , Jan. 24, 2017  It sounds ... baby,s sock that monitors vital signs and alerts ... an infant,s oxygen saturation level drops. But pediatric ... alarm to parents, with no evidence of medical ... devices are marketed aggressively to parents of healthy ...
Breaking Biology News(10 mins):
(Date:2/18/2017)... -- Kurzlehrgang mit Fokus auf Assay ... legt metaproteomische Analyse des Darm-Mikrobioms bei Säuglingen dar   ... ... Yoav Peretz , Scientific Director bei ImmuneCarta, einen Kurzlehrgang ... Nachweis intrazellulärer Zytokine bei adoptiven Zelltherapie-Studien im Rahmen der ...
(Date:2/18/2017)... ... 2017 , ... A leader in science-based, age-fighting skincare products, ... is proud to introduce its Age-Defying Night Cream, NeriumAD™ Formula, Age-Defying Day Cream, ... Hong Kong. The luxury skincare products contain innovative ingredients that fight the signs ...
(Date:2/17/2017)... , February 17, 2017 ... Market by Product (Consumables, Service), Type (Safety, Efficacy, ... Development, Drug Discovery and Development, Disease-Risk) - Global ... is projected to reach USD 53.34 Billion by ... at a CAGR of 13.8% during the forecast ...
(Date:2/17/2017)... Mass. , Feb. 17, 2017  If ... small tumor had a mutation-conferring resistance to chemotherapy, ... Recently, genomics research has focused on finding these ... or even from circulating tumor DNA in blood ... new oncology therapeutics. Unfortunately, however, detecting ...
Breaking Biology Technology: